PAN-ELR + CXC chemokine antibodies for treatment of respiratory diseases
Provided herein are methods and uses of antibodies that bind all seven human ELR + CXC chemokines with high affinity for the prevention and/or treatment of respiratory diseases, such as acute respiratory distress syndrome (ARDS). The invention also relates to doses and dosing regimens for methods and uses of antibodies that bind all seven human ELR + CXC chemokines with high affinity for the prevention and/or treatment of respiratory diseases such as ARDS..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Europäisches Patentamt - (2022) vom: 23. Dez. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
PATEL DHAVAL [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-12-23, Last update posted on www.tib.eu: 2024-02-26, Last updated: 2024-03-01 |
|---|
| Patentnummer: |
CN115515978 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA016347013 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA016347013 | ||
| 003 | DE-627 | ||
| 005 | 20240301102033.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230607s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA016347013 | ||
| 035 | |a (EPA)CN115515978 | ||
| 035 | |a (EPA)75888179 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a PATEL DHAVAL |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PAN-ELR + CXC chemokine antibodies for treatment of respiratory diseases |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2022-12-23, Last update posted on www.tib.eu: 2024-02-26, Last updated: 2024-03-01 | ||
| 520 | |a Provided herein are methods and uses of antibodies that bind all seven human ELR + CXC chemokines with high affinity for the prevention and/or treatment of respiratory diseases, such as acute respiratory distress syndrome (ARDS). The invention also relates to doses and dosing regimens for methods and uses of antibodies that bind all seven human ELR + CXC chemokines with high affinity for the prevention and/or treatment of respiratory diseases such as ARDS. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a WITCHER DERRICK RYAN |4 aut | |
| 700 | 0 | |a WOODMAN MICHAEL E |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 23. Dez. |
| 773 | 1 | 8 | |g year:2022 |g day:23 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/75888179/publication/CN115515978A1?q=CN115515978 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 23 |c 12 | ||